A survey of 10 breast cancer lines for SOCS-1–3 and CIS transcripts showed that only CIS mRNA was elevated in all transformed lines in comparison with the two phenotypically normal lines, HMEC184 and MCF-10A. This evidence concerns the gene SOCS1 and in situ carcinoma.